Venus Remedies Update by Epic Research

Venus Remedies has received its first marketing authorization in Switzerland from Swiss drug authority – Swissmedic — for Gemcitabine 200mg & 1g Injection through Venus Pharma GmbH. This market approval of critically important oncology drug Gemcitabine Injection will help Venus to strengthen its oncology portfolio.



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips